ADHEREN's innovative DNA-based live cell adhesion technology can "program" any cell surface to display synthetic DNA strands, enabling it to adhere to complementary sequences on another surface - glass slides, microplates, or another living cell. The technology was developed by a team of scientists at the University of California, Berkeley. ADHEREN was founded in 2010 to commercialize the DNA-based cell adhesion invention into powerful and useful research tools that will enable new applications, and advance live cellular analysis in the life sciences market.
There are many applications for ADHEREN's technology and products in immunology, live cell imaging, quantitative cellular analysis, high content screening, cancer research, stem cell research, and cell/tissue engineering.
Adheren’s users include researchers from academic research labs, government research institutes, and biopharmacedutical drug discovery facilities.